Preferences and willingness to pay for health states prevented by pneumococcal conjugate vaccine.
about
Values for preventing influenza-related morbidity and vaccine adverse events in children.Health-state valuations for pertussis: methods for valuing short-term health statesAutism spectrum disorders: a review of measures for clinical, health services and cost-effectiveness applicationsEconomic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model.Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United StatesPreferences for health outcomes associated with Group A Streptococcal disease and vaccination.Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study.Health benefits, risks, and cost-effectiveness of influenza vaccination of children.Cost-effectiveness of West Nile virus vaccination.A Novel Dynamic Model for Health Economic Analysis of Influenza Vaccination in the Elderly.A Framework for Including Family Health Spillovers in Economic Evaluation.Prevention of shingles: safety and efficacy of live zoster vaccine.Measuring Health Spillovers for Economic Evaluation: A Case Study in Meningitis.Pneumococcal conjugate vaccine: review of cost-effectiveness studies in Australia, North America and Europe.QALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critique.Cost effectiveness of the new pneumococcal vaccines: a systematic review of European studies.The impact of healthcare-associated methicillin-resistant Staphylococcus aureus infections on post-discharge healthcare costs and utilization.A time tradeoff method for eliciting partner's quality of life due to patient's health states in prostate cancer.Carer preferences in economic evaluation and healthcare decision making.Willingness to Pay for an Ebola Vaccine during the 2014-2016 Ebola Outbreak in West Africa: Results from a U.S. National Sample.Challenges in health state valuation in paediatric economic evaluation: are QALYs contraindicated?Measuring health and well-being effects in family caregivers of children with craniofacial malformations.Advocacy for pneumonia prevention in Korea: a multi-dimensional program organised around World Pneumonia Day
P2860
Q24805596-6EDF9BDD-121F-4696-9B87-BD74996087D9Q24805972-F2873748-1E2E-40DC-8526-9AF9CB0EECDCQ27004613-DC78AD4D-0B0E-4BE2-8179-8653274D99DEQ30371134-1A9A7466-FC98-48D3-A5F8-9A9298B517E4Q30405846-92CD3351-8238-41A0-9566-6ADAA3465B35Q33763940-D7702DBB-6F9F-4BDE-AA77-19359AC8AA15Q34316082-146196D3-F4A1-4AAF-A18D-601CBAD9FEE9Q35792094-F8512DA7-7E67-41A4-B376-1A1E9EE6E2D9Q35793943-535C9F5E-6E36-499F-A1E7-7DC5E15E9F51Q36363243-3CC7226B-183A-4242-879A-3A8DCC8A703BQ36451238-4286A651-35CF-4C2B-B03E-A6046CBF311DQ36642986-F0783035-16C7-4F04-8248-5A97548C0A5AQ37417666-5C92605A-22F5-4586-BD56-36F1732D46D9Q37763127-2275C31A-5A53-43C5-9334-431CA6ADD9F6Q37764874-419A5582-3928-4A97-8400-F8EFB2742669Q38167294-304131FC-EABC-41FE-BF40-B456500BF3C0Q41348984-F212FDE8-6C3D-4FE5-B9F7-0186D007C92AQ45347796-4C98DCE8-B2DA-4473-9D99-A81786281863Q46954520-CBD87D51-D793-4DA4-B65A-E198F28FD2BBQ47553674-52FC2F2A-FE4E-437D-A1E3-E85316C2FA77Q48664741-E44956AA-BF35-4C4C-91A0-E6B0C27E5C8BQ53048553-B69A1739-1F61-49B8-8DC8-E6491E00BA73Q59326234-D169AF8F-5AAC-4FBE-85AC-6B1287998372
P2860
Preferences and willingness to pay for health states prevented by pneumococcal conjugate vaccine.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Preferences and willingness to ...... neumococcal conjugate vaccine.
@en
type
label
Preferences and willingness to ...... neumococcal conjugate vaccine.
@en
prefLabel
Preferences and willingness to ...... neumococcal conjugate vaccine.
@en
P2093
P356
P1433
P1476
Preferences and willingness to ...... pneumococcal conjugate vaccine
@en
P2093
G Thomas Ray
Jeanne Santoli
Lisa A Prosser
Megan O'Brien
Tracy A Lieu
P304
P356
10.1542/PEDS.113.2.283
P407
P577
2004-02-01T00:00:00Z